Oragenics Inc. Faces Delisting Notice
Ticker: OGEN · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1174940
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Oragenics got a delisting notice, might be trouble.
AI Summary
Oragenics, Inc. filed an 8-K on June 18, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is located at 1990 Main Street, Suite 750, Sarasota, FL 34236, and its telephone number is 813-286-7900.
Why It Matters
This filing indicates potential issues with Oragenics' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- 1990 Main Street Suite 750 Sarasota , FL 34236 (address) — Principal executive offices
- 813 - 286-7900 (phone_number) — Registrant's telephone number
FAQ
What specific listing rule or standard has Oragenics, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Oragenics, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 18, 2024.
What is Oragenics, Inc.'s former name or former address, if changed since the last report?
The filing indicates that there is no former name or former address change since the last report.
What is the Standard Industrial Classification (SIC) code for Oragenics, Inc.?
The Standard Industrial Classification (SIC) code for Oragenics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Oragenics, Inc.?
The fiscal year end for Oragenics, Inc. is December 31.
Filing Stats: 646 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2024-06-20 08:00:24
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 9KB
- 0001493152-24-024423.txt ( ) — 224KB
- ogen-20240618.xsd (EX-101.SCH) — 3KB
- ogen-20240618_lab.xml (EX-101.LAB) — 33KB
- ogen-20240618_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 20th day of June, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer